World’s First Microbiome Fund Swells to €160M With Major Pharma Also Chipping In

14/12/2015 - 2 minutes

The French VC firm Seventure‘s Health for Life Capital investment fund for Microbiome and Biotech has had an additional €60M pumped into it by Swiss Pharma Giant Novartis and other investors.

seventure_microbiomeHealth for Life Capital is the first and unique microbiome focused investment vehicle. Now it has been announced that Novartis and other investors have also become strategic investors, pushing the funding pool up by an additional €60M.

Seventure (listed in our top 15 VCs in Europe piece), created the first worldwide €100M fund committed to the Microbiome field (read our January review of the field here). Under the leadership of Seventure’s CEO Isabelle de Cremoux, it has surpassed the initial set objectives and supports the successful visionary strategy of Seventure Partners in the microbiome field.


We met Isabelle at the Bio Europe Conference in March, who told Labiotech that they were actively seeking the next ‘big thing’ in Microbiomics,

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!

Support Us

Become a Member